SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,851,000 | -7.5% | 4,000,000 | +14.3% | 0.21% | +18.4% |
| Q1 2022 | $4,165,000 | -57.4% | 3,500,000 | +16.7% | 0.17% | -34.3% |
| Q4 2021 | $9,780,000 | +9.4% | 3,000,000 | +50.0% | 0.26% | +32.5% |
| Q3 2021 | $8,940,000 | -3.5% | 2,000,000 | +17.6% | 0.20% | +6.4% |
| Q2 2021 | $9,265,000 | +20.8% | 1,700,000 | +65.9% | 0.19% | +39.3% |
| Q1 2021 | $7,667,000 | -5.8% | 1,025,000 | +36.7% | 0.14% | -22.9% |
| Q4 2020 | $8,138,000 | +97.8% | 750,000 | +61.1% | 0.18% | +75.0% |
| Q3 2020 | $4,115,000 | -21.2% | 465,500 | -5.0% | 0.10% | -31.5% |
| Q2 2020 | $5,223,000 | +74.0% | 490,000 | -3.2% | 0.15% | +15.0% |
| Q1 2020 | $3,001,000 | – | 506,138 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|